IL-10 Induces IL-10 in Primary Human Monocyte-Derived Macrophages via the Transcription Factor Stat31

IL-10 is an important immunosuppressive cytokine that can down-regulate expression of other cytokines and has been shown to down-regulate itself. We show, in this study, that treatment of human monocyte-derived macrophages with IL-10 induces IL-10 mRNA in a dose- and time-dependent manner with an optimum induction at 100 ng/ml and at 6 h, whereas IL-10-induced IL-10 protein can be detected at 18 h. In the same cells, IL-10 can partially suppress IL-10 mRNA induced by LPS, but only down to the level of IL-10-induced IL-10. An adenoviral luciferase reporter construct driven by the −195 IL-10 promoter, which contains a Stat motif, was readily induced by both IL-10 and LPS. Mutation of this Stat motif ablated IL-10 activation of this promoter, but not the LPS activation. Finally, we show that overexpression of a dominant-negative Stat3 protein will prevent IL-10 induction, but not LPS induction, of IL-10 mRNA. These data show that IL-10 induces IL-10 in monocyte-derived macrophages in an autocrine manner via activation of the transcription factor Stat3.

[1]  C. Polman,et al.  Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patients , 1999, Journal of Neuroimmunology.

[2]  Kevin M. McBride,et al.  STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Weiner,et al.  IL-10 is critical in the regulation of automimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic mice , 1998, Journal of Neuroimmunology.

[4]  J. Darnell,et al.  A Single Amino Acid Substitution in the v-Eyk Intracellular Domain Results in Activation of Stat3 and Enhances Cellular Transformation , 1999, Molecular and Cellular Biology.

[5]  J. Herbeuval,et al.  Recruitment of STAT3 for Production of IL-10 by Colon Carcinoma Cells Induced by Macrophage-Derived IL-61 , 2004, The Journal of Immunology.

[6]  Thomas Werner,et al.  IFN-α Induces the Human IL-10 Gene by Recruiting Both IFN Regulatory Factor 1 and Stat31 , 2003, The Journal of Immunology.

[7]  S. Dewilde,et al.  The STAT3 isoforms α and β have unique and specific functions , 2004, Nature Immunology.

[8]  Hua Yu,et al.  A critical role for Stat3 signaling in immune tolerance. , 2003, Immunity.

[9]  Y. Tone,et al.  IL-10 Gene Expression Is Controlled by the Transcription Factors Sp1 and Sp31 , 2000, The Journal of Immunology.

[10]  K. Winestock,et al.  IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. , 1995, Journal of immunology.

[11]  B. Foxwell,et al.  Interleukin‐10 suppression of myeloid cell activation — a continuing puzzle , 2004, Immunology.

[12]  Peter J. Murray,et al.  Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.

[13]  Y. Fujio,et al.  Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. , 1998, Circulation.

[14]  H. Volk,et al.  Cyclic adenosine monophosphate‐responsive elements are involved in the transcriptional activation of the human IL‐10 gene in monocytic cells , 1999, European journal of immunology.

[15]  S. Smale,et al.  A Prominent Role for Sp1 During Lipopolysaccharide- Mediated Induction of the IL-10 Promoter in Macrophages1 , 2000, The Journal of Immunology.

[16]  H. Ziegler-Heitbrock,et al.  Role of Stat3 in Lipopolysaccharide-Induced IL-10 Gene Expression1 , 2000, The Journal of Immunology.

[17]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[18]  S. Medendorp,et al.  Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis , 1996, Annals of neurology.

[19]  J. Punnonen,et al.  Monocyte-Derived CD1a+ and CD1a− Dendritic Cell Subsets Differ in Their Cytokine Production Profiles, Susceptibilities to Transfection, and Capacities to Direct Th Cell Differentiation1 , 2000, The Journal of Immunology.

[20]  K. Schenke-Layland,et al.  cAMP-induced Interleukin-10 Promoter Activation Depends on CCAAT/Enhancer-binding Protein Expression and Monocytic Differentiation* , 2003, The Journal of Biological Chemistry.

[21]  P. Barnes,et al.  Stimulus-specific inhibition of IL-5 by cAMP-elevating agents and IL-10 reveals differential mechanisms of action. , 2000, Biochemical and biophysical research communications.

[22]  Francisco Diaz-Mitoma,et al.  The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages* , 2001, The Journal of Biological Chemistry.

[23]  G. Köhler,et al.  Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. , 1997, Journal of immunology.

[24]  Satoru Fukuyama,et al.  Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor–β1 , 2006, The Journal of experimental medicine.

[25]  J. Banchereau,et al.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. de Carli,et al.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. , 1993, Journal of immunology.

[27]  J Bondeson,et al.  Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W Sterry,et al.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. , 1998, The Journal of clinical investigation.

[29]  E. Fish,et al.  Contribution of Interferon-β to the Murine Macrophage Response to the Toll-like Receptor 4 Agonist, Lipopolysaccharide* , 2006, Journal of Biological Chemistry.

[30]  David F. Richards,et al.  In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.

[31]  H. Dickensheets,et al.  The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[32]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[33]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[34]  K. Asadullah,et al.  Expression profiling of IL‐10‐regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL‐10 therapy , 2004, European journal of immunology.

[35]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[36]  C. Akdis,et al.  Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.

[37]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Liwu Li,et al.  IRAK1 Serves as a Novel Regulator Essential for Lipopolysaccharide-induced Interleukin-10 Gene Expression*♦ , 2004, Journal of Biological Chemistry.

[39]  M. Kaplan,et al.  Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells , 2005, The Journal of experimental medicine.

[40]  M. Wasik,et al.  Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[41]  F. Brennan,et al.  Expression of Constitutively Active STAT3 Can Replicate the Cytokine-suppressive Activity of Interleukin-10 in Human Primary Macrophages* , 2007, Journal of Biological Chemistry.

[42]  J. Steinke,et al.  Functional Analysis of −571 IL-10 Promoter Polymorphism Reveals a Repressor Element Controlled by Sp11 , 2004, The Journal of Immunology.